BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22649062)

  • 1. Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
    Unschuld PG; Edden RA; Carass A; Liu X; Shanahan M; Wang X; Oishi K; Brandt J; Bassett SS; Redgrave GW; Margolis RL; van Zijl PC; Barker PB; Ross CA
    Mov Disord; 2012 Jun; 27(7):895-902. PubMed ID: 22649062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
    Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
    J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical correlates of caudate atrophy in Huntington's disease.
    Padowski JM; Weaver KE; Richards TL; Laurino MY; Samii A; Aylward EH; Conley KE
    Mov Disord; 2014 Mar; 29(3):327-35. PubMed ID: 24442623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.
    Politis M; Pavese N; Tai YF; Kiferle L; Mason SL; Brooks DJ; Tabrizi SJ; Barker RA; Piccini P
    Hum Brain Mapp; 2011 Feb; 32(2):258-70. PubMed ID: 21229614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease.
    Sturrock A; Laule C; Decolongon J; Dar Santos R; Coleman AJ; Creighton S; Bechtel N; Reilmann R; Hayden MR; Tabrizi SJ; Mackay AL; Leavitt BR
    Neurology; 2010 Nov; 75(19):1702-10. PubMed ID: 21060093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers.
    Sturrock A; Laule C; Wyper K; Milner RA; Decolongon J; Dar Santos R; Coleman AJ; Carter K; Creighton S; Bechtel N; Bohlen S; Reilmann R; Johnson HJ; Hayden MR; Tabrizi SJ; Mackay AL; Leavitt BR
    Mov Disord; 2015 Mar; 30(3):393-401. PubMed ID: 25690257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal metabolite changes in Huntington's disease during disease onset.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; van Buchem MA; Roos RA; van der Grond J
    J Huntingtons Dis; 2014; 3(4):377-86. PubMed ID: 25575959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural involvement of the cingulate cortex in premanifest and early Huntington's disease.
    Hobbs NZ; Pedrick AV; Say MJ; Frost C; Dar Santos R; Coleman A; Sturrock A; Craufurd D; Stout JC; Leavitt BR; Barnes J; Tabrizi SJ; Scahill RI
    Mov Disord; 2011 Aug; 26(9):1684-90. PubMed ID: 21557312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain.
    Fayed N; Andrés E; Viguera L; Modrego PJ; Garcia-Campayo J
    Acad Radiol; 2014 Sep; 21(9):1211-7. PubMed ID: 24981958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
    Sawiak SJ; Wood NI; Morton AJ
    J Huntingtons Dis; 2016 Oct; 5(3):271-283. PubMed ID: 27662335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective emotion recognition in early HD is neuropsychologically and anatomically generic.
    Henley SM; Wild EJ; Hobbs NZ; Warren JD; Frost C; Scahill RI; Ridgway GR; MacManus DG; Barker RA; Fox NC; Tabrizi SJ
    Neuropsychologia; 2008; 46(8):2152-60. PubMed ID: 18407301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal ganglia-cortical structural connectivity in Huntington's disease.
    Novak MJ; Seunarine KK; Gibbard CR; McColgan P; Draganski B; Friston K; Clark CA; Tabrizi SJ
    Hum Brain Mapp; 2015 May; 36(5):1728-40. PubMed ID: 25640796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.
    Henley SM; Wild EJ; Hobbs NZ; Scahill RI; Ridgway GR; Macmanus DG; Barker RA; Fox NC; Tabrizi SJ
    J Neurol; 2009 Feb; 256(2):203-12. PubMed ID: 19266143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
    Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
    Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional changes of the visual cortex in early Huntington's disease.
    Coppen EM; Grond JV; Hafkemeijer A; Barkey Wolf JJH; Roos RAC
    Hum Brain Mapp; 2018 Dec; 39(12):4776-4786. PubMed ID: 30144208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural brain correlates of dementia in Huntington's disease.
    Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
    Neuroimage Clin; 2020; 28():102415. PubMed ID: 32979842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.